The effects of sustained elevated levels of circulating tissue inhibitor of metalloproteinases-1 on the development of breast cancer in mice.
Buck
T B
TB
Tumor Biology and Carcinogenesis Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Yoshiji
H
H
Harris
S R
SR
Bunce
O R
OR
Thorgeirsson
U P
UP
D015127:9,10-Dimethyl-1,2-benzanthracene; D000375:Aging / Q000097:blood; D000818:Animals; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D018093:Gelatinases / Q000037:antagonists & inhibitors; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology* / Q000517:prevention & control*; D020778:Matrix Metalloproteinase 2; D017258:Medroxyprogesterone Acetate; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D051379:Mice; D008822:Mice, Transgenic; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000097:blood* / Q000235:genetics
D019715:Tissue Inhibitor of Metalloproteinase-1; D015127:9,10-Dimethyl-1,2-benzanthracene; D017258:Medroxyprogesterone Acetate; D018093:Gelatinases; D008666:Metalloendopeptidases; D020778:Matrix Metalloproteinase 2